플러스100%마이너스

  • 화면크기
통합검색

한의약융합데이터센터


근거중심한의약 DB

Home > 한의약융합데이터센터 > 근거중심한의약 DB
Title

Modulation of endothelial function by korean red ginseng (panax ginseng c.a. Meyer) and its components in healthy individuals: a randomized controlled trial.

Authors

Jovanovski E, Peeva V, Sievenpiper JL, Jenkins AL, Desouza L, Rahelic D, Sung MK, Vuksan V.

Journal

Cardiovasc Ther.

Year

2014

Vol (Issue)

32(4)

Page

163-9.

doi

10.1111/1755-5922.12077.

PMID

24758417

Url

http://www.ncbi.nlm.nih.gov/pubmed/24758417

MeSH

Adult
Brachial Artery/drug effects*
Brachial Artery/physiology
Brachial Artery/ultrasonography
Cross-Over Studies
Double-Blind Method
Endothelium, Vascular/drug effects*
Endothelium, Vascular/physiology
Endothelium, Vascular/ultrasonography
Female
Ginsenosides/administration & dosage*
Healthy Volunteers
Humans
Male
Ontario
Panax*
Phytotherapy
Plant Extracts/administration & dosage*
Plant Roots
Plants, Medicinal
Time Factors
Vasodilation/drug effects*
Vasodilator Agents/administration & dosage*
Young Adult

Keywords

Clinical trial; Endothelial function; Flow-mediated dilation; Ginseng

한글 키워드

임상 시험; 내피세포 기능; 혈류 매개 혈관확장; 인삼

KMCRIC
Summary & Commentary

KMCRIC 비평 보기 +

Korean Study

Abstract

AIMS:
Ginseng root and its derivatives remain atop the most widely used medicinal herbs in cardiovascular disease, despite inadequate substantiation of efficacy. We previously reported the potential of Korean red ginseng (KRG) to affect vascular tone by decreasing arterial wave reflection via an unknown mechanism. Given the preclinical link between ginseng intake and vasoactivity related to nitric oxide (NO) production, we sought to directly evaluate the effects of KRG root and its major root components, on an established non-invasive measure of endothelial function.

METHODS:
In an acute, randomized, placebo-controlled, double-blind, cross-over design, 16 healthy participants (9M:7F, Age:30±9y, BMI: 24±3kg/m2 , SystolicBP/DiastolicBP: 109±11/66±8mmHg) on four occasions were administered: KRG root (3g), KRG ginsenosides extract, KRG polysaccharides extract, and cornstarch control. Extracted fractions were delivered at doses bioequivalent to those found in 3g of KRG. Flow-mediated vasodilatation (FMD) assessment, preceding a brachial blood pressure measurement, was performed at baseline and at 90- and 180- min post-treatment to assess endothelial function.

RESULTS:
KRG significantly improved FMD post-treatment. Maximal vasodilatation of Δ2.57±2.8% occurred at 180 min compared to control (Δ-0.83±2.7%, p=0.003 for all comparisons). The ginsenoside extract produced a comparable response (Δ1.75±2.6%), but not the polysaccharide fraction (Δ0.10±2.7%). Brachial blood pressure remained unchanged for all treatments (p=0.45).

CONCLUSIONS:
KRG acutely improved endothelial function in healthy individuals, which appears to be attributable to its ginsenoside containing fraction. Our data confirm preclinical data and support the potential for these compounds as targets for therapeutic strategies in disorders involving endothelial dysfunction.

국문초록

Language

영어

첨부파일